Mitchell Ho

41PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsComputational linguisticsAquaculture and fisheries stock assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 01, 2026
Heparan Sulfate Controls Nanoscale Assembly of GPC3-Wnt Receptor Complexes.

|May 07, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors.

|Apr 17, 2026
Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinoma.

|Jan 19, 2026
RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy.

Masanori Onda, Xiufen Liu, Wenlong Liu

|Jan 19, 2026
Recent advances in structural investigations of cancer antigen mesothelin and its interactions with therapeutic antibodies.

Jingyu Zhan, Mitchell Ho, Lothar Esser

|Jan 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma.

Jinchutha Duangdara, Shaoli Lin, Jessica Hong

Pageof 7

Frequent Collaborators

4 joint publications

Ira Pastan

3 joint publications

Bryan D Fleming

3 joint publications

Jingyu Zhan

3 joint publications

Nan Li